Market Research Report
Global Microarray Analysis Market Size study, By Product and Service, By Type, By Application, By End User, and Regional Forecasts 2022-2028
|Global Microarray Analysis Market Size study, By Product and Service, By Type, By Application, By End User, and Regional Forecasts 2022-2028|
Published: March 23, 2022
Bizwit Research & Consulting LLP
Delivery time: 2-3 business days
Global Microarray Analysis Market is valued approximately USD 4.77 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.6% over the forecast period 2022-2028.
Microarrays are an advanced molecular biology technique that is used for detecting the expression of numerous genes at the same time. Microarray analysis is a significant technique that uses gene chips that can tie more than a thousand RNAs at a time. Microarray analysis is majorly used to detect several types of cancer. The growing incidences of cancer, rising application areas of microarrays, coupled with the increasing availability of funding for proteomic and genomic research are the primary factors for the market growth across the globe. According to the national cancer institute, cancer is the major cause of death around the world. In 2018, there were nearly 18.1 million new cancer cases and 9.5 million cancer-related deaths occur globally. Also, the amount is likely to reach around 29.5 million new cases and 16.4 million cancer-related deaths by 2040. However, the rising use of microarrays in personalized medicine and dearth of the skilled professionals impedes the growth of the market over the forecast period of 2022-2028. Also, increasing adoption of next-generation sequencing and growing fundings for R&D activities is anticipated to act as a catalyzing factor for the market demand during the forecast period.
The key regions considered for the global Microarray Analysis market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the increasing adoption of novel technologies and the presence of the leading market players in the region. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as growing incidences of cancer and other genetic diseases, as well as the availability of funding for the proteomics and genomics research, would create lucrative growth prospects for the Microarray Analysis market across the Asia-Pacific region.
Major market players included in this report are:
Thermo Fisher Scientific, Inc.
Agilent Technologies, Inc.
Molecular Devices LLC
GE Healthcare Company
Bio-Rad Laboratories Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product and Service:
Software and Services
By End User:
Research and Academic Institutes
Pharmaceutical and Biotechnology Companies
Other End Users
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Microarray Analysis Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Value-Added Resellers (VARs)
Third-party knowledge providers
List of figures